Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$626M |
| 2 |
Warner Bros
WBD
|
+$447M |
| 3 |
Apple
AAPL
|
+$436M |
| 4 |
RTX Corp
RTX
|
+$434M |
| 5 |
Constellation Brands
STZ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$502M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$436M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$415M |
| 5 |
EA
Electronic Arts
EA
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.83% |
| 2 | Technology | 9.75% |
| 3 | Industrials | 9.36% |
| 4 | Consumer Discretionary | 8.52% |
| 5 | Healthcare | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
CALL
Aflac
AFL
$58.4B
| $1.91M | ﹤0.01% |
+17,400
| New | +$1.93M |
|
|
WHWK
1727
Whitehawk Therapeutics
WHWK
$278M
| $1.9M | ﹤0.01% |
+550,441
| New | +$1.72M |
|
1728
City Holding Co
CHCO
$2.01B
| $1.9M | ﹤0.01% |
15,882
+9,498
| +149% | +$1.16M |
|
1729
CALL
Eaton
ETN
$162B
| $1.9M | ﹤0.01% |
5,300
-3,000
| -36% | -$1.07M |
|
1730
PUT
Match Group
MTCH
$9.46B
| $1.89M | ﹤0.01% |
61,700
+2,200
| +4% | +$68.6K |
|
1731
Marathon Digital Holdings
MARA
$4.59B
| $1.89M | ﹤0.01% |
+231,400
| New | +$2.09M |
|
1732
PUT
Chipotle Mexican Grill
CMG
$47.1B
| $1.88M | ﹤0.01% |
58,800
+37,700
| +179% | +$1.39M |
|
1733
Cintas
CTAS
$81.7B
| $1.88M | ﹤0.01% |
11,103
-316,341
| -97% | -$60.6M |
|
1734
PUT
Thermo Fisher Scientific
TMO
$233B
| $1.87M | ﹤0.01% |
3,800
-23,000
| -86% | -$12.5M |
|
|
ASIC
1735
Ategrity Specialty Insurance
ASIC
$1.26B
| $1.87M | ﹤0.01% |
94,471
-76,263
| -45% | -$1.48M |
|
1736
ACM Research
ACMR
$5.61B
| $1.85M | ﹤0.01% |
+47,076
| New | +$2.5M |
|
1737
NMI Holdings
NMIH
$3.37B
| $1.85M | ﹤0.01% |
49,329
+33,880
| +219% | +$1.31M |
|
|
MNTN
1738
MNTN Inc
MNTN
$943M
| $1.85M | ﹤0.01% |
+210,235
| New | +$2.1M |
|
1739
Procept Biorobotics
PRCT
$1.18B
| $1.85M | ﹤0.01% |
+73,942
| New | +$2.08M |
|
|
FLG
1740
CALL
Flagstar Bank National Association
FLG
$5.58B
| $1.85M | ﹤0.01% |
+140,400
| New | +$1.84M |
|
1741
AdaptHealth
AHCO
$774M
| $1.85M | ﹤0.01% |
155,150
+36,208
| +30% | +$371K |
|
1742
CALL
Snap
SNAP
$9.01B
| $1.84M | ﹤0.01% |
400,000
+34,400
| +9% | +$203K |
|
|
WAY
1743
Waystar Holding Corp
WAY
$4.84B
| $1.84M | ﹤0.01% |
76,210
-431,427
| -85% | -$11.5M |
|
1744
CALL
EOG Resources
EOG
$75.8B
| $1.84M | ﹤0.01% |
12,700
-3,800
| -23% | -$461K |
|
1745
Kontoor Brands
KTB
$4.18B
| $1.83M | ﹤0.01% |
26,095
-770
| -3% | -$50.4K |
|
1746
Coastal Financial
CCB
$714M
| $1.83M | ﹤0.01% |
24,095
+21,528
| +839% | +$1.95M |
|
1747
PUT
Reddit
RDDT
$29.6B
| $1.83M | ﹤0.01% |
13,600
-13,800
| -50% | -$2.35M |
|
1748
Signet Jewelers
SIG
$3.18B
| $1.83M | ﹤0.01% |
21,632
+19,077
| +747% | +$1.74M |
|
1749
Accenture
ACN
$115B
| $1.82M | ﹤0.01% |
9,184
-38,379
| -81% | -$8.94M |
|
1750
Wabash National
WNC
$539M
| $1.81M | ﹤0.01% |
210,550
+46,826
| +29% | +$465K |
|
Similar funds
Dmitry Balyasny's Q1 2026 Portfolio in Review
As of Q1 2026, Dmitry Balyasny held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dmitry Balyasny withdrew a net $3.87B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 38% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in Silicon Laboratories worth $257M.
- Dmitry Balyasny's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
- Dmitry Balyasny added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
- Dmitry Balyasny's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
- Dmitry Balyasny fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
- Dmitry Balyasny's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
- Dmitry Balyasny opened 704 new positions and closed 911 in Q1 2026.
- Dmitry Balyasny's portfolio value fell 2.1% quarter-over-quarter to $77.1B.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.